Yüklüyor......
Saleability of anti-malarials in private drug shops in Muheza, Tanzania: a baseline study in an era of assumed artemisinin combination therapy (ACT)
BACKGROUND: Artemether-lumefantrine (ALu) replaced sulphadoxine-pymimethamine (SP) as the official first-line anti-malarial in Tanzania in November 2006. So far, artemisinin combination therapy (ACT) is contra-indicated during pregnancy by the national malaria treatment guidelines, and pregnant wome...
Kaydedildi:
Asıl Yazarlar: | , , , |
---|---|
Materyal Türü: | Artigo |
Dil: | Inglês |
Baskı/Yayın Bilgisi: |
BioMed Central
2011
|
Konular: | |
Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3167767/ https://ncbi.nlm.nih.gov/pubmed/21843328 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2875-10-238 |
Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|